FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)

FDA 510(k) K260270 · FindAir Sp. z o.o.

Substantially Equivalent

510(k) numberK260270

Submission

Device name
FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)
Applicant
FindAir Sp. z o.o.
Kraków, PL
Received
January 28, 2026
Decision date
June 2, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
CAF – Nebulizer (Direct Patient Interface)
Device class
Class II (moderate risk)
Regulation
21 CFR 868.5630
Specialty
Anesthesiology

Other 510(k)s with product code CAF

510(k)DeviceApplicantDecision
K251572eRapid with eTrack SystemCAF · Traditional Pari Respiratory Equipment, Inc.12/19/2025SE
K251659Mesh Nebulizer (H6)CAF · Traditional Qingdao Future Medical Technology Co., Ltd.11/14/2025SE
K244035Portable mesh nebulizer (JM821)CAF · Traditional Shenzhen Jermei Medical Device Technology Co.…09/19/2025SE
K243468Compressor Nebulizer (NB-1100); Compressor Nebulizer (NB-1101); Compressor Nebulizer…CAF · Traditional Joytech Healthcare Co. , Ltd.07/02/2025SE
K250022HeroTracker SenseCAF · Traditional Voluntis06/30/2025SE
K250583AdheResp Smart Breath-actuated Mesh NebulizerCAF · Traditional Hcmed Innovations Co., Ltd.06/20/2025SE
K242354AllNEBCAF · Traditional Enchant Tek Co. , Ltd.04/29/2025SE
K233553MiniSpacer® 1024, 1025, 1543 and 1024A, 1025A, 1543A Dual Spray MDI AdapterCAF · Special Thayer Medical Corporation06/18/2024SE
K232507Aerogen®Solo Nebulizer SystemCAF · Traditional Aerogen, Ltd.05/10/2024SE
K232523Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%CAF · Traditional Mankind Pharma Limited04/10/2024SE

Questions and answers

When was FindAir ONE for pMDI (FAO-MDI-V12-GRE-001) cleared by the FDA?

FindAir ONE for pMDI (FAO-MDI-V12-GRE-001) (K260270) received a 510(k) decision of Substantially Equivalent on June 2, 2026, 125 days after the submission was received.

What is the product code of K260270?

The FDA product code is CAF – Nebulizer (Direct Patient Interface), a Class II (moderate risk) device regulated under 21 CFR 868.5630.